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doi:10.1016/j.gmbhs.2012.04.022Abstract Molecular imaging using matrix-assisted laser desorption ionization/time-of-flight
mass spectrometry (MALDI-TOF MS) is effective for determining the distribution of molecules
of interest in specific tissues. It can determine the direct correlation between metabolite,
lipid, and protein expression and histology. Principle component analysis (PCA) can reduce
the dimensions of a data set while still retaining the information present in the original data
set. Using PCA to process MALDI data, samples with different statuses and ion patterns on their
MALDI mass spectra can be classified, grouped, and evaluated on the same score plot. The use
of MALDI-TOF in combination with PCA to compare the lipid, peptide, and protein profiles of
different biological specimens can then be used to diagnose disease. Because ions with signif-
icant differences between sampling regions in a tissue can be indicated using PCA, the imaging
of these “interesting peaks” can be visualized by plotting the ion intensity across the tissue
section.
Copyright ª 2012, Taiwan Genomic Medicine and Biomarker Society. Published by Elsevier
Taiwan LLC. All rights reserved.Introduction
Mass spectrometry has advanced to be a superior tool for
protein identification in proteomic strategies. It oftent of Chemistry, National Sun
., Kaohsiung 80424, Taiwan.
edu.tw (J. Shiea).
an Genomic Medicine and Biomacombines with multidimensional prefractionation tech-
niques, due to the high dynamic range of protein concen-
trations in the complex matrix, protolytic digestion and
database searching for discovering disease biomarkers.
However, very few biomarkers discovered by these strate-
gies have been successfully introduced into clinical prac-
tice. Each of these laborious sample pretreatment steps
suffers from lack of reproducibility and consistency.rker Society. Published by Elsevier Taiwan LLC. All rights reserved.
4 Y.-T. Cho et al.Since mass spectrometry owns the innate features of
accuracy, sensitivity, high speed, and automation; this
makes it be a potential tool for performing high-throughput
diagnostic analyses. Herein, we describe matrix-assisted
laser desorption/ionization time-of-flight (MALDI-TOF) mass
spectrometry combined with molecular imaging and
multivariate analysis as an efficient approach to directly
characterize potential biomarkers on tissue samples.
Principal component analysis (PCA) was used to process
mass spectra of lipid, peptide, protein, or imaging data
from bio-specimens to rapidly diagnose diseases. With the
help of statistics, the approach avoids redundant fraction-
ation procedures.MALDI imaging mass spectrometry
Matrix-assisted laser desorption/ionization time-of-flight
(MALDI-TOF) mass spectrometry is known for its high sensi-
tivity, ease of operation, and automated capabilities that
can be used for the analysis of small organic or large
biochemical compounds obtained from various sources.1e6
MALDI-TOF employs a focused laser beam to desorb and
ionize the sample, which is typically comprised of an analyte
surrounded by a large amount of organic matrix. Due to the
innate spatial resolution of the laser beam, the MALDI-TOF
apparatus can be used to study the distribution of partic-
ular chemicals or biochemical compounds on a solid sample
surface, such as a tissue. This method is known as imaging
mass spectrometry (IMS), which is the ideal approach for
determining the distribution ofmolecules of interest directly
on the sample’s surface without additional or extraneous
handling.7,8 Thus, IMS has emerged as a powerful tool for
biomarker discovery and allows for the direct correlation
between protein expression and histology.9
Based on its morphologically driven protocol, MALDI-
based IMS allows the direct evaluation of different cellsFigure 1 Experimental workflow of MALDI imaging. The MALDI im
section on a stainless steel target, then depositing the matrix and i
the spots are set by a fixed lateral resolution, and the imaging resthat are growing in a tissue. Moreover, unlike other imaging
techniques such as fluorescence imaging or magnetic
resonance imaging, MALDI-based IMS does not require prior
knowledge of the sample before analysis. This technique
can be used to determine the presence of hundreds of
compounds in a single measurement without labeling. Fig. 1
shows the MALDI-based IMS experimental workflow. The
protocol begins with cutting the frozen organ or tissue into
sections ranging between 5e20 mm in thickness and thaw-
mounting these sections onto stainless steel targets or
Indium-Tin-Oxide (ITO) slides. A traditional MALDI matrix,
such as 2,5-dihydroxybenzoic acid (2,5-DHB), -cyano-4-
hydroxycinnamic acid (-CHC), or 3,5-dimethoxy-4-hydrox-
ycinnamic acid (sinapinic acid), is then applied onto the
tissue surface by an air brush or automatic matrix-
preparation system. After a homogenous layer of fine
matrix crystals is applied onto the tissue section, the target
is transferred to the ion source of a MALDI-TOF mass
spectrometer. A laser beam is then fired across the region
of interest onto the tissue section using a set lateral reso-
lution in order to generate ions for analysis by the TOF
analyzer. The mass spectra are acquired and the imaging
results are visualized by plotting the ion intensities as
a function of the two-dimensional (2D) coordinates of the
tissue using the imaging software.
To date, MALDI-based IMS has been used in a wide
variety of applications. For example, drug metabolic
processes were studied using IMS on whole body dissections
of mice,10 and the area growing within different types of
cells on the tissue were well defined11 and the accumula-
tion of tainted chemical compounds in specific organs were
proven using IMS.12 The technique is a powerful tool for not
only characterizing biomolecules in specific regions of the
sample, but also their spatial distributions on the biological
surface. In addition, it is clear that this approach can be
integrated into clinical management for disease diagnosis
and outcome prediction.aging procedure is initiated by sectioning and mounting a tissue
rradiating a laser across the tissue surface. The mass spectra of
ults are visualized using imaging software.
Figure 2 Representative plots of PCA results used to differentiate the extracts of three cell groups (A, B, and C) obtained from
their MALDI mass spectra. (A) Score plot; (B) loading plot.
Mass spectrometry as a tool for clinical diagnosis 5Principal component analysis for processing
MALDI mass spectra data
In general, tissue specimens are highly complex systems
that consist of lipids, peptides, proteins, and salts. The
MALDI mass spectra obtained from these biological speci-
mens provide information regarding the types of molecules
in the sample. If MALDI data obtained from normal control
specimens and patients can be well classified, grouped, and
differentiated, it will be very helpful for the efficient
diagnosis of disease. MALDI data are often used to differ-
entiate lipids, expressed peptides, and proteins in
comparative analysis, but efficiently comparing very
complicated MALDI data has been a challenging issue for
scientists.
Because MALDI mass spectra are a type of multivariate
data, with each mass signal defining one molecular
dimension, the process of evaluating mass spectra usingFigure 3 IMS images generated from signals at (A) m/z 741 (Sphi
34:1 + K), and (C) m/z 820 (Phosphatidylcholine, PC 36:4 + K) frommultivariate statistical methods allows the straightforward
differentiation of samples.Principle component analysis
(PCA), a multivariate method designed to extract the
variance within a data set, is one of the most widely used
statistical methods used for differentiation. PCA reduces
the dimensionality of the data set while retaining the
information present in the original data set. By reducing
the dimensionality of the data set to a 2D or 3D coordinate
system, in which each sample (spectrum) is represented by
a point, spectra with similar variation characteristics can
be clustered together and the differences between sample
groups can be readily visualized in the system. Because the
first two principal components - PC1 and PC2 usually
provide more than 80% of the total variance between the
samples, it is sufficient to express the original multidi-
mensional data matrix in a 2D plot, i.e., PC2 vs. PC1. PCA in
combination with MS has been applied to the fields of
metabolomics, proteomics, and MALDI-based IMSstudies.
Fig. 2 shows the representative plots of the PCA resultsngomyelin, SM 16:0 + K), (B) m/z 798 (Phosphatidylcholine, PC
renal samples obtained from a rat.
6 Y.-T. Cho et al.used for differentiating extracted MALDI mass spectra from
three different cells. The PCA score plot indicates the
similarities and differences between the ion patterns of the
mass spectra of the three samples. The loading plots of the
PCA analysis provide information regarding the contribution
of each ion signal to the variance covered by each
respective principle component.
The concept of using MALDI-TOF in combination with
statistical processing to compare the lipid, peptide, or
protein profiles of biological specimens, which carry
abundant disease-related molecular information, can be
used to rapidly diagnose diseases.13 After the optimized
experimental procedures are determined, samples can be
analyzed using MALDI-TOF. PCA is then used to process all of
the mass spectrometric data. This is different from the
conventional approach where qualitative and quantitative
data of specific biomarkers are used to diagnose certain
diseases. Because the time required to complete MALDI-
TOF and PCA analyses is usually short, these types of
bioanalytical approaches for diagnosing diseases allows
large-scale screening to become a reality.
Processing MALDI imaging data using PCA
MALDI-based IMS provides information on specific molecular
distributions in a tissue. The information can then be
correlated with clinical data on certain diseases. For
example, it was found that the molecular patterns detec-
ted on the tissues of a developing tumor, invasive tumor,
and normal epithelia are different. The molecular image
based on specific signal markers can then be used to
determine the areas with different states. Because MALDI-
based IMS records a large number of mass spectra from
a tissue section, finding the representative mass spectra
and choosing the interesting peaks and biomarkers that
display significant differences between tissues states have
become important issues.Peak-by-peak interpretation of
MALDI-based IMS data is a labor- and time-consuming
process and inefficient. One of the efficient approaches is
using PCA to process IMS data in order to reduce the
complexity of the information of the multivariate data
sets.14,15 The grouped results in the score plot provide
classification information regarding the tissue state. The
loading plots of the PCA analysis can indicate the ion signals
with significant differences between regions or tissues, and
the imaging of these interesting peaks can be visualized by
plotting the ion intensities across the tissue section. By
using multivariate statistical methods, the chemical noise
and the irrelevant features are eliminated and more
concise information is obtained.
Previously, many studies used PCA to differentiate
MALDI mass spectra recorded from different types of
samples and process MALDI imaging data using PCA to
diagnose disease. In our laboratory, several studies have
been done using the same approach including: (1) the study
of the distribution of melamine and lipids on rat renal
tissues by IMS (Fig. 3)12; (2) rapid differentiation of the
virulence of Helicobacter pylori using MALDI-TOF and PCAanalyses; (3) combining MALDI-TOF and PCA for differenti-
ating breast cancer cell lines with different Estrogen
Receptor (ER) and Human Epidermal Growth Factor
Receptor 2 (HER-2) statuses; and (4) applying MALDI-based
IMS to define cancer regions in breast tissue. In conclusion,
through the success of many studies, MALDI-TOF and MALDI-
based IMS together with PCA have become techniques that
are not only useful for academic research but also practical
tools for clinical diagnosis.
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